SpaceX IPO: Will It Be a Buy or a Bust?

SpaceX confidentially filed to go public on April 1, targeting a $2 trillion valuation and a potential $75 billion raise, which would eclipse all prior IPOs. Reuters cites 2025 revenue of $15–16B and roughly $8B EBITDA; at a $2T valuation the company would trade near ~130x sales and ~250x EBITDA. SpaceX merged with xAI in Feb 2026 in a share-exchange deal valuing the combined group at $1.25T ($1T SpaceX, $250B xAI), shifting private capital structure ahead of the IPO. Analyst view is negative on valuation disconnect with fundamentals and recommends caution given the high price and downside risk.

Analysis

The SpaceX/xAI combination and an anticipated mega-IPO introduce a flood of structural supply (primary shares) and psychological supply (employee liquidity + pre-IPO paper) into public markets that will replay across high-P/S, narrative-driven names. Expect a 6–12 month window where growth multiple compression is concentrated in AI-adjacent and Elon-linked equities as investors reassess what portion of future AI upside belongs to a newly public, vertically integrated platform versus incumbent chip and software providers.

Second-order winners include exchange operators and IPO bankers (fee capture), specialty aerospace suppliers (radiation-hardened components, launch integration services) and AI software vendors that can be bundled with Starlink/X; losers are speculative AI pure-plays that trade on story instead of revenue, plus any private funds forced to mark-to-market following a large primary sale. Regulatory and national-security reviews (satellite comms, data routing, export controls) and lock-up expiries are high-probability catalysts that can create 10–40% moves in weeks, while genuine operational milestones (Starlink ARPU, xAI commercial contracts, demonstrable space-based compute tests) play out over 1–3 years.

From a portfolio stance, treat this as a crystallization event rather than an innovation dividend: trim uncompensated concentration in narrative growth names, harvest realized gains into durable-exposure instruments (infrastructure, exchanges, diversified chip supply). Opportunistic, hedged exposures capture upside from AI infrastructure demand (NVDA/INTC) while shorting sentiment-driven re-ratings (Musk/Elon-linked consumer growth stories) over the next 3–12 months; execute with defined-risk derivative structures to survive the binary headline cadence around filing, roadshow, and lock-up windows.

Key Decisions for Investors

• Long PLTR (stock or 12–18 month LEAP calls) — sizing 2–4% notional. Rationale: cheaper multiple vs narrative peers; benefits if enterprises shift to on-prem/edge AI integrated with satellite comms. Target +60–100% in 12–18 months; stop-loss at -30% or hedge with short-dated puts to limit drawdown.
• Buy NDAQ 6–12 month calls (near-the-money) — sizing 1–2% notional. Rationale: direct beneficiary of any mega-IPO listing fees and secondary trading volume uplift. Expect a 15–40% bump on S-1 filing/roadshow; cut if filing delayed >90 days or regulatory headlines escalate.
• Bull call spread on NVDA (3–9 month) — modest allocation (1% notional). Rationale: hardware demand optionality if xAI scales and satellite edge-inference becomes viable; use call spread to limit premium outlay. Target 30–60% return on premium; max loss = premium paid.
• Protective position on TSLA: buy 12–18 month put spread or short 1–2% notional — defined-risk hedge against Musk-linked sentiment repricing. Rationale: spillover negative sentiment and liquidity needs could pressure Musk-linked equities. Expect hedge to pay off during headline-driven drawdowns; cap cost via spread to maintain carry.